[Aquaretic agents].
Jiménez
W
W
Laboratorio Hormonal, Hospital Clínic, Barcelona.
D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D051399:Aquaporin 2; D051403:Aquaporin 6; D020346:Aquaporins / Q000502:physiology; D001201:Ascites / Q000188:drug therapy* / Q000209:etiology; D044482:Benzeneacetamides; D001834:Body Water; D003707:Demeclocycline / Q000494:pharmacology / Q000627:therapeutic use; D004231:Diuresis / Q000187:drug effects*; D004232:Diuretics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007685:Kidney Tubules, Collecting / Q000187:drug effects / Q000502:physiology; D008103:Liver Cirrhosis / Q000150:complications / Q000503:physiopathology*; D008106:Liver Cirrhosis, Experimental / Q000150:complications / Q000503:physiopathology; D009025:Morpholines / Q000494:pharmacology / Q000627:therapeutic use; D011759:Pyrrolidines / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D017473:Receptors, Opioid, kappa / Q000819:agonists; D017483:Receptors, Vasopressin / Q000145:classification / Q000502:physiology; D013141:Spiro Compounds / Q000494:pharmacology / Q000627:therapeutic use; D014667:Vasopressins / Q000502:physiology
C496023:AQP2 protein, human; D065092:Antidiuretic Hormone Receptor Antagonists; C496025:Aqp2 protein, rat; D051399:Aquaporin 2; D051403:Aquaporin 6; D020346:Aquaporins; D044482:Benzeneacetamides; D004232:Diuretics; D009025:Morpholines; D011759:Pyrrolidines; D017473:Receptors, Opioid, kappa; D017483:Receptors, Vasopressin; D013141:Spiro Compounds; D014667:Vasopressins; D003707:Demeclocycline; C103281:satavaptan; C100946:niravoline